- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Merus Labs International announced it has received regulatory approval to sell Sintrom in Spain.
Merus Labs International (TSX:MSL, NASDAQ:MSLI) announced it has received regulatory approval to sell Sintrom in Spain.
As quoted in the press release:
Merus has now received approvals that represent roughly 80% of our overall targeted tech transfer savings. This benefit is realized once products sourced from prior suppliers are sold. As previously communicated, the Company expects an estimated $4 million of cost savings from Sintrom® to be realized in fiscal 2017.
Today’s approval for the Spanish market for the new Sintrom® active pharmaceutical ingredient (API) supplier represents the second of two steps in the tech transfer process. This submission was very complex and consisted of over 60 separate variations. This milestone in Spain, a market representing approximately 50% of Sintrom® sales, represents almost $2 million of the estimated annualized tech transfer savings of $8 million.
Click here to read the full press release.
Source: www.newswire.ca
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â